Moderna Inc (NASDAQ: MRNA) Will Approach FDA For Full Approval For...

0
Moderna Inc (NASDAQ: MRNA) will seek the full approval of the US FDA for its covid vaccine. The move allows the company to stay...

Ocugen Inc (NASDAQ: OCGN) Enters The Canadian Market With Covaxin: Explores...

0
Ocugen Inc (NASDAQ: OCGN) in alliance with Bharat Biotech develops Covid vaccine – Covaxin, which can act against new coronavarius variants. 

PERFORMANCE TRAINING

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) Releases Cohort 4 C-144-01 Study Data In Advanced Melanoma

0
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) has announced preliminary data from vital Cohort 4 as well as updated Cohort 2 data in its C-144-01 lifileucel study...

AGC Biologics achieves the on-schedule Completion of a drug substance PPQ Campaign with Provention...

0
AGC Biologics strives to offer scaled expertise in the manufacturing of protein-based therapeutics through its integrated service offerings. Its interest begins right from the...

Moderna Inc (NASDAQ:MRNA) And CordenPharma Extend Their Lipids Supply Deal For Covid-19 Vaccine Development

0
CordenPharma has announced the extension of its lipids supply agreement with pharmaceutical giant Moderna Inc (NASDAQ:MRNA) for the production of its COVID-19 vaccine. Moderna is...

Competing Narratives and the Future of CorMedix Inc. (NYSEAMERICAN:CRMD)

0
CorMedix Inc. (NYSEAMERICAN:CRMD) is still largely about Neutrolin, the company’s prize asset targeting the reduction and prevention of catheter-related infections and thrombosis in patients requiring...

ChemoCentryx Inc (NASDAQ:CCXI) Files New Drug Application For Avacopan As An ANCA-associated vasculitis Treatment

0
ChemoCentryx Inc (NASDAQ:CCXI) recently revealed that it submitted a New Drug Application (NDA) for avacopan as an indication for ANCA-associated vasculitis. The company attached clinical...

[/tdc_zone]

.td-post-views{ display: none !important; }